The Technical Analyst
Nutra Pharma Corp. [NPHC]
Exchange: OTC Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
Nutra Pharma Corp. Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% $0.0001
America/New_York / 1 mai 2024 @ 10:50
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 0.760 mill |
| EPS: | 0.0100 |
| P/E: | 0.0100 |
| Earnings Date: | May 29, 2024 |
| SharesOutstanding: | 7 596.85 mill |
| Avg Daily Volume: | 0.252 mill |
| RATING 2024-03-15 |
|---|
| A- |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Neutral | |
| Return On Asset: | Buy | |
| DE: | Sell | |
| P/E: | Strong Buy | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
| Revenue | n/a | n/a | n/a | |||
| Gr.Profit | n/a | n/a | n/a | |||
| Ebit | n/a | n/a | n/a | |||
| Asset | n/a | n/a | n/a | |||
| Debt | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 0.0100 | sector: PE 29.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.00x |
| Company: PE 0.0100 | industry: PE 31.46 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.0001 - 0.0001 ( +/- 0.00%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2021-11-15 | Deitsch Rik J | Sell | 0 | Common Stock |
| 2016-12-19 | Deitsch Rik J | Buy | 15 000 000 | Nutra Pharma Corp Common Stock |
| 2016-07-05 | Deitsch Rik J | Buy | 15 000 000 | Nutra Pharma Corp Common Stock |
| 2016-06-28 | Deitsch Rik J | Buy | 4 000 000 | Nutra Pharma Corp Common Stock |
| 2015-06-13 | Deitsch Rik J | Buy | 4 000 000 | Nutra Pharma Corp Common Stock |
| INSIDER POWER |
|---|
| 0.00 |
| Last 77 transactions |
| Buy: 266 812 000 | Sell: 22 679 990 |
Forecast: